Man Group
PRAH

Man Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Man Group’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-33,617
Closed -$5.16M – 2170
2021
Q1 		$5.16M Sell
33,617
-30,475
-48% -$4.14M 0.02% 675
2020
Q4 		$8.04M Sell
64,092
-63,573
-50% -$7.11M 0.04% 539
2020
Q3 		$12.9M Buy
127,665
+80,535
+171% +$8.21M 0.05% 392
2020
Q2 		$4.58M Buy
47,130
+25,074
+114% +$2.33M 0.02% 717
2020
Q1 		$1.83M Sell
22,056
-98,607
-82% -$9.62M 0.01% 915
2019
Q4 		$13.4M Buy
120,663
+91,559
+315% +$9.42M 0.04% 527
2019
Q3 		$2.89M Sell
29,104
-57,353
-66% -$5.7M 0.01% 1116
2019
Q2 		$8.57M Sell
86,457
-19,147
-18% -$1.83M 0.03% 700
2019
Q1 		$11.6M Buy
105,604
+64,837
+159% +$6.78M 0.04% 508
2018
Q4 		$3.75M Sell
40,767
-52,236
-56% -$5.29M 0.02% 916
2018
Q3 		$10.2M Buy
93,003
+66,860
+256% +$6.96M 0.04% 610
2018
Q2 		$2.44M Buy
26,143
+9,429
+56% +$812K 0.01% 1282
2018
Q1 		$1.39M Buy
+16,714
New +$1.49M 0.01% 1407

Other funds holding PRAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Man Group's PRAH Position: Q2 2021 in Review

Man Group sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 33,617 shares — an estimated $5.16M sold.

Man Group first reported a position in PRAH in Q1 2018 and held it in 13 quarters. The position peaked at $13.4M in Q4 2019. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • Man Group reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Man Group sold 33,617 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $5.16M.
  • Man Group first reported a position in PRA Health Sciences, Inc. in Q1 2018 and held it in 13 quarters.
  • Man Group's PRA Health Sciences, Inc. position peaked at $13.4M in Q4 2019.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Man Group's 13F filing for Q2 2021, filed 16 Aug 2021.